3,5-Dicaffeoylquinic Acid Suppresses Breast Cancer Progression by Targeting TP53/cMyc/H19 Axis and Downstream MicroRNAs to Modulate MIF, Gal-3, and Gal-9 Lolowa M. Elsherbiny Amira Abdel Motaal H. El-Askary T. Manie Rana A. Youness Aug 2026 · Journal of Pharmaceutical Innovation · Vol 22 · 0 citations · 80 references DOI Semantic Scholar Save View source Cite { copied='apa'; setTimeout(() => { copied=null; open=false }, 1000) })" class="flex w-full items-center justify-between rounded-lg px-3 py-2 text-left text-sm hover:bg-gray-100 dark:hover:bg-ink-800"> Copy APA Copied ✓ { copied='mla'; setTimeout(() => { copied=null; open=false }, 1000) })" class="flex w-full items-center justify-between rounded-lg px-3 py-2 text-left text-sm hover:bg-gray-100 dark:hover:bg-ink-800"> Copy MLA Copied ✓ { copied='bibtex'; setTimeout(() => { copied=null; open=false }, 1000) })" class="flex w-full items-center justify-between rounded-lg px-3 py-2 text-left text-sm hover:bg-gray-100 dark:hover:bg-ink-800"> Copy BibTeX Copied ✓ Share